Importantly, cyclin D1 overexpression leads to uncontrolled cell proliferation and is linked to the development, progression, poor prognosis, and chemoresistance of a broad range of human malignancies, including colorectal cancer, thus making cyclin D1 a potential therapeutic target [27,28]. The gene discussed is CCND1; the disease is colorectal cancer.